Stockreport

Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting [Yahoo! Finance]

Calidi Biotherapeutics, Inc.  (CLDI) 
PDF Showcased preclinical data on RTNova (CLD-400) platform's ability to survive bloodstream and reach all tumors systemically Non-clinical data supporting the upcoming S [Read more]